Variable |  | <40 years | ≥50 years |
---|---|---|---|
Gender | Male | 26 (51%) | 26(45%) |
 | Female | 27 (49%) | 21(55%) |
Duration of symptoms* | ≤ 3 months | 22 (41.5%) | 22 (47%) |
 | >3 months | 31 (58.5%) | 25 (53%) |
Tumour Location | Right colon (included 2 synchronous lesions in <40 year group) | 10 (17.5%) | 3 (6%) |
 | Left colon (included 2 synchronous lesions in <40 year group) | 10 (17.5%) | 13(28%) |
 | Rectal | 37 (65%) | 31 (66%) |
Histological types | Adenocarcinoma (included 4 synchronous lesions in the young) | 48 (84%) | 43 (92%) |
 | Mucinous | 5 (9%) | 2 (4%) |
 | Signet ring | 4 (7.0%) | 2 (4%) |
Tumor grade | Well | 10 (18.9%) | 2 (4%) |
 | Moderate | 33 (62.2%) | 43(92%) |
 | Poor | 10 (18.9%) | 2 (4%) |
T stage | T0/1 | 5 (9.2%) | 2 (4%) |
 | T2 | 11 (20.4%) | 9 (19%) |
 | T3 | 24 (44.4%) | 28 (60%) |
 | T4 | 11 (20.4%) | 8 (17%) |
 | No residual tumor after chemoradiation | 3 (5.6%) | Nil |
N stage | N0 | 28 (51.8%) | 25(54.3%) |
 | N1 | 13 (24.1%) | 8 (17.4%) |
 | N2 | 13 (24.1%) | 13 (28.3%) |
AJCC staging * | I | 7 (14.0%) | 6 (12.8%) |
 | II | 16 (32.0%) | 20 (42.6%) |
 | III | 24 (48.0%) | 15 (31.9%) |
 | IV | 3 (6.0%) | 6 (12.8%) |
Pre-operative CEA level (ng/ml) | <5.0 | 17 (51.5%) | 16 (34%) |
 | >5.0 | 16 (48.5%) | 31(66%) |
Resection margin # | R0 | 40 (80.0%) | 35 (74.5%) |
 | R1 | 10 (20.0%) | 12 (25.5%) |